These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 29706843)

  • 1. NIRF Optical/PET Dual-Modal Imaging of Hepatocellular Carcinoma Using Heptamethine Carbocyanine Dye.
    Zhang C; Zhao Y; Zhao N; Tan D; Zhang H; Chen X; Zhang H; An J; Shi C; Li M
    Contrast Media Mol Imaging; 2018; 2018():4979746. PubMed ID: 29706843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CD146-targeted immunoPET and NIRF Imaging of Hepatocellular Carcinoma with a Dual-Labeled Monoclonal Antibody.
    Hernandez R; Sun H; England CG; Valdovinos HF; Ehlerding EB; Barnhart TE; Yang Y; Cai W
    Theranostics; 2016; 6(11):1918-33. PubMed ID: 27570560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Theranostic imaging of liver cancer using targeted optical/MRI dual-modal probes.
    Chen Q; Shang W; Zeng C; Wang K; Liang X; Chi C; Liang X; Yang J; Fang C; Tian J
    Oncotarget; 2017 May; 8(20):32741-32751. PubMed ID: 28416757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Application of Heptamethine Cyanine Dye DZ-1 and Indocyanine Green for Imaging and Targeting in Xenograft Models of Hepatocellular Carcinoma.
    Zhang C; Zhao Y; Zhang H; Chen X; Zhao N; Tan D; Zhang H; Shi C
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28635650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optical imaging of gastric cancer with near-infrared heptamethine carbocyanine fluorescence dyes.
    Zhao N; Zhang C; Zhao Y; Bai B; An J; Zhang H; Wu JB; Shi C
    Oncotarget; 2016 Aug; 7(35):57277-57289. PubMed ID: 27329598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Site-specifically labeled CA19.9-targeted immunoconjugates for the PET, NIRF, and multimodal PET/NIRF imaging of pancreatic cancer.
    Houghton JL; Zeglis BM; Abdel-Atti D; Aggeler R; Sawada R; Agnew BJ; Scholz WW; Lewis JS
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):15850-5. PubMed ID: 26668398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Conjugate of Pentamethine Cyanine and
    An FF; Kommidi H; Chen N; Ting R
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28590411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PET imaging of hepatocellular carcinoma by targeting tumor-associated endothelium using [
    Lu Q; Long Y; Fan K; Shen Z; Gai Y; Liu Q; Jiang D; Cai W; Wan C; Lan X
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4000-4013. PubMed ID: 35763056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting MMP-14 for dual PET and fluorescence imaging of glioma in preclinical models.
    Kasten BB; Jiang K; Cole D; Jani A; Udayakumar N; Gillespie GY; Lu G; Dai T; Rosenthal EL; Markert JM; Rao J; Warram JM
    Eur J Nucl Med Mol Imaging; 2020 Jun; 47(6):1412-1426. PubMed ID: 31773232
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
    Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
    Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
    [No Abstract]   [Full Text] [Related]  

  • 11. Near-Infrared Heptamethine Cyanine Based Iron Oxide Nanoparticles for Tumor Targeted Multimodal Imaging and Photothermal Therapy.
    Lee S; George Thomas R; Ju Moon M; Ju Park H; Park IK; Lee BI; Yeon Jeong Y
    Sci Rep; 2017 May; 7(1):2108. PubMed ID: 28522841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles-based pre-targeting strategy enables multi-modal imaging of orthotopic colon cancer and image-guided surgery.
    Jing B; Qian R; Jiang D; Gai Y; Liu Z; Guo F; Ren S; Gao Y; Lan X; An R
    J Nanobiotechnology; 2021 May; 19(1):151. PubMed ID: 34022897
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Heptamethine carbocyanine DZ-1 dye for near-infrared fluorescence imaging of hepatocellular carcinoma.
    An J; Zhao N; Zhang C; Zhao Y; Tan D; Zhao Y; Bai B; Zhang H; Wu BJ; Shi C
    Oncotarget; 2017 Aug; 8(34):56880-56892. PubMed ID: 28915639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual-Modality Immuno-PET and Near-Infrared Fluorescence Imaging of Pancreatic Cancer Using an Anti-Prostate Stem Cell Antigen Cys-Diabody.
    Zettlitz KA; Tsai WK; Knowles SM; Kobayashi N; Donahue TR; Reiter RE; Wu AM
    J Nucl Med; 2018 Sep; 59(9):1398-1405. PubMed ID: 29602820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Pretargeted Approach for the Multimodal PET/NIRF Imaging of Colorectal Cancer.
    Adumeau P; Carnazza KE; Brand C; Carlin SD; Reiner T; Agnew BJ; Lewis JS; Zeglis BM
    Theranostics; 2016; 6(12):2267-2277. PubMed ID: 27924162
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dual-Modality Imaging of Prostate Cancer with a Fluorescent and Radiogallium-Labeled Gastrin-Releasing Peptide Receptor Antagonist.
    Zhang H; Desai P; Koike Y; Houghton J; Carlin S; Tandon N; Touijer K; Weber WA
    J Nucl Med; 2017 Jan; 58(1):29-35. PubMed ID: 27516447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heptamethine carbocyanine dye-mediated near-infrared imaging of canine and human cancers through the HIF-1α/OATPs signaling axis.
    Shi C; Wu JB; Chu GC; Li Q; Wang R; Zhang C; Zhang Y; Kim HL; Wang J; Zhau HE; Pan D; Chung LW
    Oncotarget; 2014 Oct; 5(20):10114-26. PubMed ID: 25361418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PET/NIR Fluorescence Bimodal Imaging for Targeted Tumor Detection.
    Xue X; Li Q; Zhang P; Xue Y; Zhao Y; Ye Y; Li J; Li Y; Zhao L; Shao G
    Mol Pharm; 2023 Dec; 20(12):6262-6271. PubMed ID: 37948165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluorescence- and multispectral optoacoustic imaging for an optimized detection of deeply located tumors in an orthotopic mouse model of pancreatic carcinoma.
    Napp J; Stammes MA; Claussen J; Prevoo HAJM; Sier CFM; Hoeben FJM; Robillard MS; Vahrmeijer AL; Devling T; Chan AB; de Geus-Oei LF; Alves F
    Int J Cancer; 2018 May; 142(10):2118-2129. PubMed ID: 29277891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-Modality Image-Guided Surgery of Prostate Cancer with a Radiolabeled Fluorescent Anti-PSMA Monoclonal Antibody.
    Lütje S; Rijpkema M; Franssen GM; Fracasso G; Helfrich W; Eek A; Oyen WJ; Colombatti M; Boerman OC
    J Nucl Med; 2014 Jun; 55(6):995-1001. PubMed ID: 24700882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.